CAS: 5293-84-5; (Chloromethyl)Triphenylphosphoniumchloride

该化合物是一种多用途磷盐,广泛用于有机合成,特别是用于为维蒂格反应准备氟化物,其主要优点在于其作为稳定磷酰胺的前体的活性,能够高选择性地合成烷.在标准条件下,化合物的稳定性和易于处理,使它成为实验室应用的实际选择.它也被用于改变聚合物,并用作制药和农用化学研究的中间体.它的存在增强了其在核生殖反应中的效用,进一步扩大了其合成用途.

结构式图片

相似化合物

1034-49-7 1031-15-8 3020-28-8

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号56-23-5 四氯化碳 | CAS号603-35-0 三苯基膦 | CAS号5293-83-4 (羟基甲基)三苯基氯化鏻 | CAS号50-00-0 甲醛 | CAS号18370-19-9 1-[2-chloro-1-(... | CAS号27444-11-7 (2-chloro-1-cyc... | CAS号103774-26-1 5,9-dimethyldec... | CAS号1100-88-5 苄基三苯基氯化磷 | CAS号110637-64-4 (((dimethylcarb... | CAS号68089-86-1 (氯甲基)三苯基碘化膦 | CAS号4541-89-3 (2-chloro-1-phe... | CAS号622-25-3 (2-chlorovinyl)... | CAS号1138147-84-8 (1E,3E,5Z)-1-br... | CAS号1138147-83-7 (1E,3E,5E)-1-br...

合成工艺路线路线简述

    (羟基甲基)三苯基氯化鏻置于氯化亚砜体系中,用 二氯甲烷 作为反应溶剂,化学反应 1.0H,以18.0 G的收率获得产物(氯甲基)三苯基氯化磷
    参考文献:The Synthesis Of Benzylphosphine Oxides Via Vicarious Nucleophilic Substitution And Alkenes Via Vns-horner-wittig Reactions
    标题:The Synthesis Of Benzylphosphine Oxides Via Vicarious Nucleophilic Substitution And Alkenes Via Vns-horner-wittig Reactions
    摘要:一系列取代的硝基苯与(氯甲基)二苯基氧化膦的阴离子发生反应,通过亲核取代作用反应生成取代的硝基苯基二苯基氧化膦.介绍了通过一锅替代亲核取代霍纳维蒂希反应立体选择性合成二苯乙烯的新方法.
    DOI:10.1039/b206144A

    海关参考信息

    专利信息


    专利号:US-8067394-B2
    优先权日:2006-11-17
    标 题:Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
    发明人:HONDA TADASHI; SUNDARARAJAN CHITRA; GRIBBLE GORDON W; SPORN MICHAEL B; LIBY KAREN T
    权利人:HONDA TADASHI; SUNDARARAJAN CHITRA; GRIBBLE GORDON W; SPORN MICHAEL B; LIBY KAREN T; DARTMOUTH COLLEGE
    摘要:This invention describes novel tricyclic-bis-enone derivatives (TBEs), such as TBE-31, TBE-34, TBE-45 and water-soluble TBEs. The methods of preparing these compounds are also disclosed. The inventors demonstrate the ability of these new TBEs to inhibit proliferation of human myeloma cells, inhibit the induction of iNOS in cells stimulated with interferon-γ, induce heme oxygenase-1 (HO-1), induce CD11b expression—a leukemia differentiation marker, inhibit proliferation of leukemia cells, induce apoptosis in human lung cancer, and induce apoptosis in other cancerous cells. The TBEs of this invention are expected to be useful agents for the treatment and prevention of many diseases, including cancer, neurological disorders, inflammation, and pathologies involving oxidative stress.

    专利号:WO-2014151181-A1
    优先权日:2013-03-15
    标题 :A novel method for synthesizing tbe-31
    发明人:HONDA TADASHI; SAITO AKIRA; ZHENG SUQING
    权利人:UNIV NEW YORK STATE RES FOUND
    摘要:A process for the synthesis of (±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10,10a-octahydrophenanthrene-2,6-dicarbonitrile ('TBE-31'), which is useful for the treatment of various diseases and disorder in mammals. (±)-8a-(Hydroxymethyl)-1,4a-dimethyl-2,3,4,4a,6,7,8,8a,9,10-decahydrophenanthren-2-ol; (±)-8a-(Hydroxymethyl)-1,4a-dimethyl-4,4a,6,7,8,8a,9,10-octahydrophenanthren-2(3H)-one; (±)-(2R,4aS,8aS)-8a-(Hydroxymethyl)-1,4a-dimethyl-2,3,4,4a,6,7,8,8a,9,10-decahydrophenanthren-2-ol; (±)-(2S,4aS,8aS)-8a-(Hydroxymethyl)-1,4a-dimethyl-2,3,4,4a,6,7,8,8a,9,10-decahydrophenanthren-2-ol; and (±)-(4aS,8aS)-8a-(Hydroxymethyl)-1,4a-dimethyl-4,4a,6,7,8,8a,9,10-octahydrophenanthren-2(3H)-one (4).

    专利号:DE-202024103926-U1
    优先权日:2024-07-13
    标题 :Composition and system for the synthesis of zirconocene dichloride catalyst for the production of indiacene A and indiacene B

    专利号:US-7714012-B2
    优先权日:2006-11-17
    标 题 :Synthesis and biological activities of new tricyclic-bis-enones (TBEs)

    专利号:US-2008261985-A1
    优先权日:2006-11-17
    标 题:Synthesis and biological activities of new tricyclic-bis-enones (tbes)

    专利号:RU-2172740-C2
    优先权日:1993-02-08
    标 题 :Active component of medicinal preparation, steroid, method of its synthesis and pharmaceutical composition
    安庆合生药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:18055625120👤
    ⚠️参考联系方式
    地址:安徽省安庆市高新区皇冠路8号安庆生命科技园. 邮编:430000
    电话:18055625120;15102708508
    传真:QQ:1339589636
    邮箱:1339589636@qq.com
    联系人:尹经理
    手机:18055625120;15102708508
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽省安庆市高新区皇冠路8号安庆生命科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#04073
    摘要:Lindenschmidt, A., Science of Synthesis, (2007) 25, 257.
    摘要:Schobert, R.; Gordon, G. J., Science of Synthesis, (2004) 27, 981.
    摘要:Leroy, B., Science of Synthesis, (2007) 29, 280.
    摘要:Pollex, A., Science of Synthesis, (2008) 32, 483.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知